These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20739753)

  • 1. Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice.
    Skurnik D; Merighi M; Grout M; Gadjeva M; Maira-Litran T; Ericsson M; Goldmann DA; Huang SS; Datta R; Lee JC; Pier GB
    J Clin Invest; 2010 Sep; 120(9):3220-33. PubMed ID: 20739753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine.
    Cerca N; Jefferson KK; Maira-Litrán T; Pier DB; Kelly-Quintos C; Goldmann DA; Azeredo J; Pier GB
    Infect Immun; 2007 Jul; 75(7):3406-13. PubMed ID: 17470540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine.
    Maira-Litrán T; Kropec A; Goldmann DA; Pier GB
    Infect Immun; 2005 Oct; 73(10):6752-62. PubMed ID: 16177353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy.
    Skurnik D; Kropec A; Roux D; Theilacker C; Huebner J; Pier GB
    Clin Infect Dis; 2012 Nov; 55(9):1188-97. PubMed ID: 22806596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.
    Maira-Litrán T; Bentancor LV; Bozkurt-Guzel C; O'Malley JM; Cywes-Bentley C; Pier GB
    PLoS One; 2012; 7(9):e43813. PubMed ID: 22970144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opsonic and protective properties of antibodies raised to conjugate vaccines targeting six Staphylococcus aureus antigens.
    Pozzi C; Wilk K; Lee JC; Gening M; Nifantiev N; Pier GB
    PLoS One; 2012; 7(10):e46648. PubMed ID: 23077517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens.
    Cywes-Bentley C; Skurnik D; Zaidi T; Roux D; Deoliveira RB; Garrett WS; Lu X; O'Malley J; Kinzel K; Zaidi T; Rey A; Perrin C; Fichorova RN; Kayatani AK; Maira-Litràn T; Gening ML; Tsvetkov YE; Nifantiev NE; Bakaletz LO; Pelton SI; Golenbock DT; Pier GB
    Proc Natl Acad Sci U S A; 2013 Jun; 110(24):E2209-18. PubMed ID: 23716675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the opsonic and protective activity against Staphylococcus aureus of fully human monoclonal antibodies specific for the bacterial surface polysaccharide poly-N-acetylglucosamine.
    Kelly-Quintos C; Cavacini LA; Posner MR; Goldmann D; Pier GB
    Infect Immun; 2006 May; 74(5):2742-50. PubMed ID: 16622211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of epitope specificity in the human opsonic antibody response to the staphylococcal surface polysaccharide poly N-acetyl glucosamine.
    Kelly-Quintos C; Kropec A; Briggs S; Ordonez CL; Goldmann DA; Pier GB
    J Infect Dis; 2005 Dec; 192(11):2012-9. PubMed ID: 16267775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to Staphylococcus aureus capsular polysaccharides 5 and 8 perform similarly in vitro but are functionally distinct in vivo.
    Liu B; Park S; Thompson CD; Li X; Lee JC
    Virulence; 2017 Aug; 8(6):859-874. PubMed ID: 27936346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against Staphylococcus aureus by antibody to the polyglycerolphosphate backbone of heterologous lipoteichoic acid.
    Theilacker C; Kropec A; Hammer F; Sava I; Wobser D; Sakinc T; Codée JD; Hogendorf WF; van der Marel GA; Huebner J
    J Infect Dis; 2012 Apr; 205(7):1076-85. PubMed ID: 22362863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly-N-acetylglucosamine production in Staphylococcus aureus is essential for virulence in murine models of systemic infection.
    Kropec A; Maira-Litran T; Jefferson KK; Grout M; Cramton SE; Götz F; Goldmann DA; Pier GB
    Infect Immun; 2005 Oct; 73(10):6868-76. PubMed ID: 16177366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of cross-opsonic effect leads to the discovery of PPIase-domain containing protein vaccine candidate to prevent infections by Gram-positive ESKAPE pathogens.
    Sadones O; Kramarska E; Laverde D; Berisio R; Huebner J; Romero-Saavedra F
    BMC Microbiol; 2024 Jul; 24(1):280. PubMed ID: 39068414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to Staphylococcus aureus serotype 8 capsular polysaccharide react with and protect against serotype 5 and 8 isolates.
    Park S; Gerber S; Lee JC
    Infect Immun; 2014 Dec; 82(12):5049-55. PubMed ID: 25245803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge.
    Fattom AI; Sarwar J; Ortiz A; Naso R
    Infect Immun; 1996 May; 64(5):1659-65. PubMed ID: 8613375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide.
    Cerca N; Maira-Litrán T; Jefferson KK; Grout M; Goldmann DA; Pier GB
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7528-33. PubMed ID: 17446272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease.
    Tkaczyk C; Hamilton MM; Sadowska A; Shi Y; Chang CS; Chowdhury P; Buonapane R; Xiao X; Warrener P; Mediavilla J; Kreiswirth B; Suzich J; Stover CK; Sellman BR
    mBio; 2016 Jun; 7(3):. PubMed ID: 27353753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective opsonic activity of antibodies against fibronectin-binding proteins (FnBPs) of Staphylococcus aureus.
    Rozalska B; Wadström T
    Scand J Immunol; 1993 May; 37(5):575-80. PubMed ID: 8484103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection and characterization of murine monoclonal antibodies to Staphylococcus aureus iron-regulated surface determinant B with functional activity in vitro and in vivo.
    Brown M; Kowalski R; Zorman J; Wang XM; Towne V; Zhao Q; Secore S; Finnefrock AC; Ebert T; Pancari G; Isett K; Zhang Y; Anderson AS; Montgomery D; Cope L; McNeely T
    Clin Vaccine Immunol; 2009 Aug; 16(8):1095-104. PubMed ID: 19553551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to Conserved Surface Polysaccharides Protect Mice Against Bacterial Conjunctivitis.
    Zaidi TS; Zaidi T; Pier GB
    Invest Ophthalmol Vis Sci; 2018 May; 59(6):2512-2519. PubMed ID: 29847658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.